Literature DB >> 16000847

Expression of retinoblastoma protein in human growth hormone-secreting pituitary adenomas.

Ines Donangelo1, Heliomar Pereira Marcos, Paula Bruna Araújo, Jorge Marcondes, Paulo Niemeyer Filho, Mônica Gadelha, Leila Chimelli.   

Abstract

The retinoblastoma gene (RB1) is a tumor-suppressor gene in chromosomal region 13q14.2. Its role in the pathogenesis of pituitary tumors has not been fully clarified. Some studies have shown that losses in this chromosomal region are related to aggressive tumor behavior, although the retinoblastoma protein (pRB) is still expressed. Conversely, lack of expression of pRB was observed in one fourth of GH-secreting pituitary adenomas (GH-tumors). In order to further study the expression of pRB in GH-tumors, we evaluated this protein in 49 tumors from patients with acromegaly (20 noninvasive, 25 invasive, and 4 with no information) and 8 normal pituitaries using immunohistochemistry (IHC). Nuclear staining for pRB ranged from 0 to 90% (median 40%) in the tumors and from 40 to 80% (median 58%) in normal pituitaries. In 10 tumors (20% of total) the adenomatous cells were negative (5 cases) or had very low labeling (5 cases) for pRB. Sixty three percent (31/49) of the tumors showed staining in 10-80% of the cells and in 16% (8/49) of the cases >80% of the adenomatous cells were positive for pRB. The expression of pRB was not different in invasive and noninvasive tumors. In conclusion, pRB is underexpressed in a subgroup of GH-tumors, and this may represent an early event in the pathogenesis of this tumor subtype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000847     DOI: 10.1385/ep:16:1:053

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   4.056


  51 in total

1.  A cosmid and cDNA fine physical map of a human chromosome 13q14 region frequently lost in B-cell chronic lymphocytic leukemia and identification of a new putative tumor suppressor gene, Leu5.

Authors:  B Kapanadze; V Kashuba; A Baranova; O Rasool; W van Everdink; Y Liu; A Syomov; M Corcoran; A Poltaraus; V Brodyansky; N Syomova; A Kazakov; R Ibbotson; A van den Berg; R Gizatullin; L Fedorova; G Sulimova; A Zelenin; L Deaven; H Lehrach; D Grander; C Buys; D Oscier; E R Zabarovsky; S Einhorn; N Yankovsky
Journal:  FEBS Lett       Date:  1998-04-17       Impact factor: 4.124

2.  Analysis of the MEN1 gene in sporadic pituitary adenomas from Japanese patients.

Authors:  K Fukino; Y Kitamura; N Sanno; A Teramoto; M Emi
Journal:  Cancer Lett       Date:  1999-09-20       Impact factor: 8.679

3.  Somatic MEN1 gene mutation does not contribute significantly to sporadic pituitary tumorigenesis.

Authors:  J Poncin; A Stevenaert; A Beckers
Journal:  Eur J Endocrinol       Date:  1999-06       Impact factor: 6.664

4.  Mutations of the MEN1 tumor suppressor gene in pituitary tumors.

Authors:  Z Zhuang; S Z Ezzat; A O Vortmeyer; R Weil; E H Oldfield; W S Park; S Pack; S Huang; S K Agarwal; S C Guru; P Manickam; L V Debelenko; M B Kester; S E Olufemi; C Heppner; J S Crabtree; A L Burns; A M Spiegel; S J Marx; S C Chandrasekharappa; F S Collins; M R Emmert-Buck; L A Liotta; S L Asa; I A Lubensky
Journal:  Cancer Res       Date:  1997-12-15       Impact factor: 12.701

5.  Molecular characterization of the men1 tumor suppressor gene in sporadic pituitary tumors.

Authors:  T R Prezant; J Levine; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1998-04       Impact factor: 5.958

6.  Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.

Authors:  D J Simpson; N A Hibberts; A M McNicol; R N Clayton; W E Farrell
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

7.  Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas.

Authors:  C Tanaka; T Kimura; P Yang; M Moritani; T Yamaoka; S Yamada; T Sano; K Yoshimoto; M Itakura
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

8.  The retinoblastoma gene in human pituitary tumors.

Authors:  V L Cryns; J M Alexander; A Klibanski; A Arnold
Journal:  J Clin Endocrinol Metab       Date:  1993-09       Impact factor: 5.958

9.  Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.

Authors:  S Takeuchi; H P Koeffler; D R Hinton; I Miyoshi; S Melmed; I Shimon
Journal:  J Endocrinol       Date:  1998-05       Impact factor: 4.286

10.  Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase.

Authors:  A Spada; M Arosio; D Bochicchio; N Bazzoni; L Vallar; M Bassetti; G Faglia
Journal:  J Clin Endocrinol Metab       Date:  1990-12       Impact factor: 5.958

View more
  7 in total

1.  Sca1⁺ murine pituitary adenoma cells show tumor-growth advantage.

Authors:  Ines Donangelo; Song-Guang Ren; Tamar Eigler; Clive Svendsen; Shlomo Melmed
Journal:  Endocr Relat Cancer       Date:  2014-01-30       Impact factor: 5.678

2.  Tumor deletion mapping of chromosomal region 13q14 in 43 growth hormone secreting pituitary adenomas.

Authors:  Ines Donangelo; Paula Bruna Araújo; Daniela Antenuzi; Mariana Farage; Jorge Marcondes; Paulo Niemeyer Filho; Mônica R Gadelha
Journal:  Endocrine       Date:  2005-11       Impact factor: 3.633

3.  Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.

Authors:  Matthew Miller; Shenglin Chen; Jeffrey Woodliff; Sanjay Kansra
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

Review 4.  Clinical and molecular genetics of acromegaly: MEN1, Carney complex, McCune-Albright syndrome, familial acromegaly and genetic defects in sporadic tumors.

Authors:  Anelia Horvath; Constantine A Stratakis
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

Review 5.  Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

Authors:  Albert Beckers; Lauri A Aaltonen; Adrian F Daly; Auli Karhu
Journal:  Endocr Rev       Date:  2013-01-31       Impact factor: 19.871

6.  The expression of AIP-related molecules in elucidation of cellular pathways in pituitary adenomas.

Authors:  Elina Heliövaara; Anniina Raitila; Virpi Launonen; Anders Paetau; Johanna Arola; Heli Lehtonen; Timo Sane; Robert J Weil; Outi Vierimaa; Pasi Salmela; Karoliina Tuppurainen; Markus Mäkinen; Lauri A Aaltonen; Auli Karhu
Journal:  Am J Pathol       Date:  2009-10-22       Impact factor: 4.307

7.  Discovery of transcriptional regulators and signaling pathways in the developing pituitary gland by bioinformatic and genomic approaches.

Authors:  Michelle L Brinkmeier; Shannon W Davis; Piero Carninci; James W MacDonald; Jun Kawai; Debashis Ghosh; Yoshihide Hayashizaki; Robert H Lyons; Sally A Camper
Journal:  Genomics       Date:  2009-02-11       Impact factor: 5.736

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.